Tdam USA Inc. Decreases Stake in CME Group Inc. (NASDAQ:CME)
Tdam USA Inc. lowered its stake in CME Group Inc. (NASDAQ:CME) by 18.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 254,230 shares of the financial services provider’s stock after selling 56,147 shares during the period. CME Group accounts for about 1.6% of Tdam USA Inc.’s holdings, making the stock its 8th largest position. Tdam USA Inc. owned 0.07% of CME Group worth $31,789,000 as of its most recent filing with the SEC.
Other institutional investors have also recently modified their holdings of the company. Huntington National Bank raised its position in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the last quarter. Coconut Grove Bank raised its position in shares of CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock valued at $107,000 after buying an additional 440 shares during the last quarter. Whittier Trust Co. raised its position in shares of CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock valued at $122,000 after buying an additional 115 shares during the last quarter. Parallel Advisors LLC raised its position in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after buying an additional 43 shares during the last quarter. Finally, RidgeWorth Capital Management LLC raised its position in shares of CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock valued at $135,000 after buying an additional 406 shares during the last quarter. 83.29% of the stock is currently owned by institutional investors.
Shares of CME Group Inc. (NASDAQ CME) opened at 125.83 on Monday. The company has a 50-day moving average of $123.71 and a 200-day moving average of $120.57. CME Group Inc. has a 12 month low of $98.95 and a 12 month high of $127.96. The firm has a market cap of $42.60 billion, a P/E ratio of 25.68 and a beta of 0.73.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925 million during the quarter, compared to the consensus estimate of $931.05 million. During the same quarter in the prior year, the firm earned $1.14 EPS. The company’s revenue for the quarter was up 2.1% compared to the same quarter last year. Equities analysts forecast that CME Group Inc. will post $4.82 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.10%. The ex-dividend date is Thursday, September 7th. CME Group’s dividend payout ratio is presently 53.99%.
Several brokerages have recently weighed in on CME. UBS AG reiterated a “buy” rating and set a $134.00 target price (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. Royal Bank Of Canada set a $135.00 target price on shares of CME Group and gave the stock a “buy” rating in a research note on Tuesday, August 1st. BidaskClub upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Thursday. Jefferies Group LLC reiterated a “buy” rating and set a $128.00 target price on shares of CME Group in a research note on Monday, July 10th. Finally, Citigroup Inc. began coverage on shares of CME Group in a research note on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price for the company. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $131.63.
In other CME Group news, Director Ronald A. Pankau sold 300 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $124.78, for a total value of $37,434.00. Following the completion of the transaction, the director now owns 4,009 shares in the company, valued at approximately $500,243.02. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Chairman Terrence A. Duffy sold 21,815 shares of the company’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the completion of the transaction, the chairman now owns 110,711 shares of the company’s stock, valued at approximately $13,715,985.79. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 69,770 shares of company stock valued at $8,569,114. Insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.